Transforming Cancer Screening and Diagnosis
Saving and Improving Lives

Creatv Bio's Liquid Biopsy


Innovative blood test for early detection and diagnosis of cancer
when it matters most

Monitoring Residual Disease and Recurrence

  • For all cancers

  • Minimal Residual Disease

  • Early detection of recurrence

  • Companion diagnostics - not requiring tissue

  • Provide aggressiveness of the cancer

  • Provide whole tumor DNA for sequencing

Cancer Diagnostics

Monitoring Therapy

  • Assay applicable to all cancers

  • Enhance patient selection

  • Provide prognosis at any time

  • Provide information on treatment response

  • Provide companion diagnostics - not requiring tissue

  • Validate drug targets

  • Deliver high quality DNA for sequencing

Streamline Drug Development and Clinical Trials

  • Provide information on response to new therapy in ~30 days

  • Sequential monitoring of therapy

5/30/2025 Press Release

Clinical Trials Demonstrate Monitoring PD-L1 Upregulation Using LifeTracDx Blood Test Could Support New Treatment Path for Metastatic Triple Negative Breast Cancer